Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase ...

A “patient” which rests in a hospital bed at a former elementary school building can do everything from cough to scream to go ...

Epinephrine is a commonly used agent for a variety of indications and clinical scenarios within the emergency department. It is commonly administered during cardiopulmonary arrest and serves as an ...

Researchers at Mass General Brigham and Karolinska Institutet have identified a new method to predict asthma exacerbations ...

Researchers from Hiroshima University in Japan and collaborating institutions have found that adults with asthma who ...

Associations between asthma and dementia differed based on the patient’s age and asthma control, according to a study ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...

Depemokimab-ulaa (Exdensur) is approved for severe asthma with an eosinophilic phenotype, offering protection with just two doses annually. Phase 3 trials demonstrated significant reductions in asthma ...

A monthly injection for managing severe asthma could help patients safely reduce or even discontinue daily steroid medications, according to a new phase 3b clinical trial published in The Lancet ...